EP3237108A1 - Traitement d'hydrogel de cellulose nanofibrillaire à température élevée - Google Patents
Traitement d'hydrogel de cellulose nanofibrillaire à température élevéeInfo
- Publication number
- EP3237108A1 EP3237108A1 EP15828499.2A EP15828499A EP3237108A1 EP 3237108 A1 EP3237108 A1 EP 3237108A1 EP 15828499 A EP15828499 A EP 15828499A EP 3237108 A1 EP3237108 A1 EP 3237108A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nanofibrillar cellulose
- cellulose hydrogel
- heat treatment
- hydrogel
- seconds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920002678 cellulose Polymers 0.000 title claims abstract description 293
- 239000001913 cellulose Substances 0.000 title claims abstract description 291
- 239000000017 hydrogel Substances 0.000 title claims abstract description 235
- 238000010438 heat treatment Methods 0.000 claims abstract description 115
- 238000000034 method Methods 0.000 claims abstract description 63
- 244000005700 microbiome Species 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 206010061592 cardiac fibrillation Diseases 0.000 claims description 18
- 230000002600 fibrillogenic effect Effects 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 17
- 125000000129 anionic group Chemical group 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 8
- 238000004113 cell culture Methods 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 4
- 235000010980 cellulose Nutrition 0.000 description 242
- 230000001332 colony forming effect Effects 0.000 description 19
- 239000000523 sample Substances 0.000 description 10
- 238000012258 culturing Methods 0.000 description 8
- 230000036512 infertility Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 238000004537 pulping Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 241001148470 aerobic bacillus Species 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000002023 wood Substances 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 229920005610 lignin Polymers 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000589220 Acetobacter Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000011121 hardwood Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 239000011122 softwood Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 244000283070 Abies balsamea Species 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 241000589212 Acetobacter pasteurianus Species 0.000 description 1
- 244000235858 Acetobacter xylinum Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000198134 Agave sisalana Species 0.000 description 1
- 235000011624 Agave sisalana Nutrition 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000014466 Douglas bleu Nutrition 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 240000000797 Hibiscus cannabinus Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 240000000907 Musa textilis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 240000001416 Pseudotsuga menziesii Species 0.000 description 1
- 235000005386 Pseudotsuga menziesii var menziesii Nutrition 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- YLFIGGHWWPSIEG-UHFFFAOYSA-N aminoxyl Chemical compound [O]N YLFIGGHWWPSIEG-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000012865 aseptic processing Methods 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- AIXMJTYHQHQJLU-UHFFFAOYSA-N chembl210858 Chemical compound O1C(CC(=O)OC)CC(C=2C=CC(O)=CC=2)=N1 AIXMJTYHQHQJLU-UHFFFAOYSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000001964 microbiological growth medium Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012414 sterilization procedure Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000000930 thermomechanical effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H11/00—Pulp or paper, comprising cellulose or lignocellulose fibres of natural origin only
- D21H11/16—Pulp or paper, comprising cellulose or lignocellulose fibres of natural origin only modified by a particular after-treatment
- D21H11/18—Highly hydrated, swollen or fibrillatable fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0052—Preparation of gels
- B01J13/0069—Post treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
Definitions
- the invention relates to a method for treating nanofibrillar cellulose hydrogel.
- the invention further relates a nanofibrillar cellulose hydrogel, to a system for treating a nanofibrillar cellulose hydrogel, and to the use of the nanofibrillar cellulose hydrogel.
- a nanofibrillar cellulose hydrogel has been found use in different applications such as in cosmetics and pharmaceuticals as well as in cell growth medium.
- the use thereof in cosmetic or pharmaceutical products or devices put challenges on ensuring that the hydrogel is aseptic or sterile as well as on its other properties that may be affected by the used sterilization procedure.
- sterilization efficiency is defined as the ability to remove or destroy all forms of microbial life, including viruses, bacteria and fungi, under vegetative forms or spores.
- SAL security assurance level
- the worldwide accepted definition of sterility of medical devices is defined as the chance of finding a viable organism in or on a medical device to be at most 1 in 1000000 or an SAL of at most 10 "6 .
- the number of viable micro-organisms in nanofibrillar cellulose hydrogel can be reduced or eliminated by subjecting the hydrogel to autoclaving for 20 minutes at a temperature of 121 °C .
- Autoclaving has some challenges as it affects the properties, such as viscosity, of the hydrogel.
- the inventors have therefore recognized the need for a method to treat nanofibrillar cellulose hydrogel such that it is suitable for further applications .
- the purpose of the invention is to provide a new type of a method for treating a nanofibrillar cellulose hydrogel. Further the purpose of the invention is to provide a new type of nanofibrillar cellulose hydrogel and new uses of nanofibrillar cellulose hydrogel. Further the purpose of the invention is to provide a new system for treating a nanofibrillar cellulose hydrogel.
- nanofibrillar cellulose hydrogel according to the present invention is characterized by what is presented in claims 16 or 21.
- Fig. 1 is a flow chart illustration of the system according to one embodiment of the present invention .
- the present invention relates to a method for treating a nanofibrillar cellulose hydrogel, wherein the method comprises the steps of: providing a nanofibrillar cellulose hydrogel; and subjecting the nanofibrillar cellulose hydrogel to heat treatment, wherein the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds, for reducing the number of viable micro-organisms in the nanofibrillar cellulose hydrogel.
- the method for treating a nanofibrillar cellulose hydrogel comprises the steps of: providing a nanofibrillar cellulose hydrogel having a dry-matter content of at least 0.6 weight-%; and subjecting the nanofibrillar cellulose hydrogel to a heat treatment, wherein the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds, for reducing the number of viable micro-organisms in the nanofibrillar cellulose hydrogel.
- the present invention further relates to a system for treating a nanofibrillar cellulose hydrogel, wherein the system comprises: a fibrillation unit for providing a nanofibrillar cellulose hydrogel, wherein the fibrillation unit is configured to fibrillate a cellulose-based raw material; and a heating apparatus for subjecting the nanofibrillar cellulose hydrogel to a heat treatment, wherein the heating apparatus is configured to keep the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds, for reducing the number of viable micro- organisms in the nanofibrillar cellulose hydrogel.
- the system for treating a nanofibrillar cellulose hydrogel comprises: a fibrillation unit for providing a nanofibrillar cellulose hydrogel, wherein the fibrillation unit is configured to fibrillate a cellulose-based raw material; and a heating apparatus for subjecting the nanofibrillar cellulose hydrogel to a heat treatment, wherein the heating apparatus is configured to keep the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds, for reducing the number of viable micro-organisms in the nanofibrillar cellulose hydrogel, and wherein the fibrillation unit and the heating apparatus are configured to maintain aseptic conditions.
- the fibrillation unit fibrillates the cellulose-based raw material.
- the heating apparatus keeps the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds.
- the present invention further relates to the use a heat treatment for reducing the number of viable micro-organism in nanofibrillar cellulose hydrogel, wherein the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds.
- the heat treatment is used for reducing the number of viable micro-organisms in a nanofibrillar cellulose hydrogel having a dry-matter content of at least 0.6 weight-%, wherein the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds.
- the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of at least 133 °C, or of at least 135 °C, for at least 0.5 seconds.
- the operating pressures are to be selected so that the desired temperature is reached and the nanofibrillar cellulose hydrogel is not boiling in the used temperature.
- Nanofibrillar cellulose itself is not a volatile component and it does not boil.
- the pressure is higher than vapor pressure of water in the nanofibrillar cellulose hydrogel in the desired temperature.
- the inventor of the present invention surprisingly found out that treating the nanofibrillar cellulose hydrogel at a rather high temperature for a rather short period of time has the effect of reducing or eliminating the number of viable micro-organisms in the hydrogel without compromising, in an adverse extent, the other properties, such as the viscosity, of the nanofibrillar cellulose hydrogel, which would affect its suitability to be further used in e.g. cosmetic or pharmaceutical products or devices.
- the inventor of the present invention found out that the heat treatment at a high temperature for a short period of time may not affect the viscosity of the hydrogel in a similar manner as e.g. autoclaving does.
- hydrogel or "nanofibrillar cellulose hydrogel” should be understood in this specification, unless otherwise stated, as referring to an aqueous dispersion of nanofibrillar cellulose having a continuous or discontinuous gel structure.
- a “discontinuous” gel structure is to be understood a continuous gel, which is broken into pieces.
- the hydrogel can be formed by combining nanofibrillar cellulose with e.g. water, buffer solution, cell culture medium or any other aqueous solution optionally supplemented with additives.
- the storage modulus (G' ) value of the nanofibrillar cellulose hydrogel is greater than its loss modulus (G") value, i.e.
- the storage modulus G' , loss modulus G" and loss tangent (G"/G') of nanofibrillar cellulose hydrogels can be determined with the frequency sweep in dynamic oscillation mode of the rheometer (strain 1 % and 10 %, frequency 0.1-100, temperature 25 °C, pH 7.0). Stress sweep is measured in a shear stress range of 0,001 - 100 Pa at the frequency of 0.1 Hz, and at a temperature of 25 °C and at pH 7. For characterizing the gel forming capacity of nanofibrillar cellulose the measurement is performed in 0.5 weight-%, 1 % strain, and frequency of 0.1 Hz.
- the storage modulus of oxidized nanofibrillar celluloses may vary from 1 to 100 Pa, or from 2 to 50 Pa, or from 5 to 20 Pa, in water at 0.5 weight-% concentration.
- nanofibril cellulose or “NFC” should be understood in this specification, unless otherwise stated, as referring to a collection of isolated cellulose nanofibrils (CNF) or nanofibril bundles derived from cellulose-based raw material.
- the fibrils can be isolated from cellulose based raw material.
- cellulose-based raw material should be understood in this specification, unless otherwise stated, as referring to any raw material source that contains cellulose and from which nanofibrillar cellulose can be produced.
- the cellulose-based raw material is based on any plant material that contains cellulose.
- Plant material may be wood.
- Wood can be from softwood tree such as spruce, pine, fir, larch, douglas-fir or hemlock, or from hardwood tree such as birch, aspen, poplar, alder, eucalyptus or acacia, or from a mixture of softwoods and hardwoods.
- Non-wood material can be from agricultural residues, grasses or other plant substances such as straw, leaves, bark, seeds, hulls, flowers, vegetables or fruits from cotton, corn, wheat, oat, rye, barley, rice, flax, hemp, manila hemp, sisal hemp, jute, ramie, kenaf, bagasse, bamboo or reed.
- agricultural residues, grasses or other plant substances such as straw, leaves, bark, seeds, hulls, flowers, vegetables or fruits from cotton, corn, wheat, oat, rye, barley, rice, flax, hemp, manila hemp, sisal hemp, jute, ramie, kenaf, bagasse, bamboo or reed.
- the cellulose-based raw material is derived from a bacterial fermentation process. In one embodiment, the cellulose based raw material is derived from cellulose-producing micro ⁇ organism.
- the micro-organisms can be of the genus Acetobacter, Agrobacterium, Rhizobium, Pseudomonas or Alcaligenes, preferably of the genus Acetobacter, and more preferably of the species Acetobacter xylinum or Acetobacter pasteurianus .
- Nanofibrils typically have a high aspect ratio. The length might exceed one micrometer while the diameter is typically below 200 nm. The smallest nanofibrils are similar to so called elementary fibrils, which are typically 2 - 12 nm in diameter. The dimensions of the fibrils or fibril bundles are dependent on raw material and disintegration method.
- the number average diameter of nanofibrillar cellulose may vary from 1 to 100 nm, such as from 1 to 50 nm, or from 2 to 15 nm.
- native or non-derivatized grades have larger diameters and wider fibril size distribution while derivatized grades have smaller diameters and narrower size distributions.
- Fibril thickness and width distribution may be measured by image analysis of images from a field emission scanning electron microscope (FE-SEM) , a transmission electron microscope (TEM) , such as a cryogenic transmission electron microscope (cryo-TEM) , or an atomic force microscope (AFM) .
- FE-SEM field emission scanning electron microscope
- TEM transmission electron microscope
- cryo-TEM cryogenic transmission electron microscope
- AFM atomic force microscope
- Nanofibrillar cellulose is characterized by very high water retention values, a high degree of chemical accessibility and the ability to form stable gels, hydrogels, in water or other polar solvents.
- Nanofibrillar cellulose product is typically a dense network of highly fibrillated cellulose.
- a dispersion of cellulose nanofibers forms a viscoelastic hydrogel network.
- the hydrogel is formed at relatively low concentrations of for example 0.05 - 0.2 % w/w by dispersed and hydrated entangled fibrils.
- the step of providing a nanofibrillar cellulose hydrogel comprises providing a nanofibrillar cellulose hydrogel having a dry-matter content of at least 0.6 weight-%, or at least 0.7 weight-%, or at least 0.8 weight-%, or at least 0.9 weight-%, or at least 1 weight-%. In one embodiment, the step of providing a nanofibrillar cellulose hydrogel comprises providing a nanofibrillar cellulose hydrogel having a dry-matter content of at most 4 weight-%, or at most 3 weight-%, or at most 2 weight-%.
- the nanofibrillar cellulose hydrogel to be subjected to heat treatment has a dry- matter content of at least 0.6 weight-%, or at least 0.7 weight-%, or at least 0.8 weight-%, or at least 0.9 weight-%, or at least 1 weight-%. In one embodiment, the nanofibrillar cellulose hydrogel to be subjected to heat treatment has a dry-matter content of at most 4 weight-%, or at most 3 weight-%, or at most 2 weight-%.
- the nanofibrillar cellulose hydrogel to be subjected to heat treatment has a dry- matter content of 0.6 - 4 weight-%, or 0.7 - 3 weight- %, or 0.8 - 2 weight-%.
- the heat treatment comprises: heating the nanofibrillar cellulose hydrogel up to a temperature of at least 130 °C in at most 5 seconds; and keeping the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds.
- the heat treatment comprises: heating the nanofibrillar cellulose hydrogel up to a temperature of at least 133 °C in at most 5 seconds; and keeping the nanofibrillar cellulose hydrogel at a temperature of at least 133 °C for at least 0.5 seconds.
- the heat treatment comprises: heating the nanofibrillar cellulose hydrogel up to a temperature of at least 135 °C in at most 5 seconds; and keeping the nanofibrillar cellulose hydrogel at a temperature of at least 135 °C for at least 0.5 seconds.
- the method comprises, after the heat treatment, the step of cooling the nanofibrillar cellulose hydrogel to a temperature of below 30 °C in at most 120 seconds.
- the nanofibrillar cellulose hydrogel is packed after the step of cooling the nanofibrillar cellulose hydrogel.
- the cooling has the effect of preventing evaporation of water from the nanofibrillar cellulose hydrogel after it has been packed for storage or for further use.
- the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 130 - 150 °C for at most 30 seconds, or at most 15 seconds, or at most 4 seconds, or for 1 - 2 seconds.
- the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 130 - 150 °C for at most 30 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 130 - 150 °C for at most 15 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 130 - 150 °C for at most 4 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 130 - 150 °C for 1 - 2 seconds .
- the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 133 - 150 °C for at most 30 seconds, or at most 15 seconds, or at most 4 seconds, or for 1 - 2 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 133 - 150 °C for at most 30 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 133 - 150 °C for at most 15 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 133 - 150 °C for at most 4 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 133 - 150 °C for 1 - 2 seconds .
- the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 135 - 150 °C for at most 30 seconds, or at most 15 seconds, or at most 4 seconds, or for 1 - 2 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 135 - 150 °C for at most 30 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 135 - 150 °C for at most 15 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 135 - 150 °C for at most 4 seconds. In one embodiment the heat treatment comprises keeping the nanofibrillar cellulose hydrogel at a temperature of 135 - 150 °C for 1 - 2 seconds .
- the method comprises an additional sterilization treatment before the heat treatment.
- the additional sterilization treatment comprises an additional heat treatment .
- the nanofibrillar cellulose hydrogel to be subjected to the heat treatment contains at most 10 6 colony-forming units of a viable micro ⁇ organism per gram of nanofibrillar cellulose hydrogel, or at most 10 4 colony-forming units of a viable micro ⁇ organism per gram of nanofibrillar cellulose hydrogel, or at most 10 3 colony-forming units of a viable micro- organism per gram of nanofibrillar cellulose hydrogel.
- the nanofibrillar cellulose hydrogel to be subjected to the heat treatment may contain essentially only aerobic microorganisms. Anaerobes may not be commonly found in nanofibrillar cellulose hydrogels, especially not in wood-derived nanofibrillar cellulose hydrogels.
- the number of viable micro ⁇ organisms in the nanofibrillar cellulose hydrogel is reduced by a factor of at least 10 3 , or at least 10 6 , or at least 10 12 . In one embodiment the number of viable micro-organisms in the nanofibrillar cellulose hydrogel is reduced by a factor of at least 10 3 . In one embodiment the number of viable micro-organisms in the nanofibrillar cellulose hydrogel is reduced by a factor of at least 10 6 . In one embodiment the number of viable micro-organisms in the nanofibrillar cellulose hydrogel is reduced by a factor of at least 10 12 . Pharmaceutical products and medical devices may require sterility of the material or may require that the material is aseptic.
- sterility of the hydrogel or "sterile” should be understood in this specification, unless otherwise stated, as referring to a nanofibrillar cellulose hydrogel comprising fewer than 1 cfu (colony-forming units) , or fewer than 10 _1 cfu, or fewer than 10 ⁇ 2 cfu, or fewer than 10 ⁇ 3 cfu, or fewer than 10 ⁇ 4 cfu, or fewer than 10 ⁇ 5 cfu, or fewer than 10 ⁇ 6 cfu of a viable microorganism per gram of the nanofibrillar cellulose hydrogel.
- the nanofibrillar cellulose hydrogel comprises fewer than 10 ⁇ 6 cfu of a viable microorganism per gram of the nanofibrillar cellulose hydrogel, there is a probability of not more than one viable microorganism in one million grams of the nanofibrillar cellulose hydrogel.
- a "colony-forming unit” is a term that describes the formation of a single macroscopic colony after the introduction of one or more microorganisms to microbiological growth media. One colony forming unit is expressed as 1 CFU.
- the heat treatment is carried out by contacting the nanofibrillar cellulose hydrogel with steam.
- the heat treatment can be carried out by so-called direct heating methods, such as steam injection or steam infusion, wherein the nanofibrillar cellulose hydrogel is mixed with heating steam.
- the heating apparatus is configured to contact the nanofibrillar cellulose hydrogel with steam.
- the heat treatment is carried out by so-called indirect heating method, using e.g. a plate heat exchanger or a tubular heat exchanger, which keep the nanofibrillar cellulose hydrogel and the heating medium separate with a barrier between them.
- the heating apparatus is a heat exchanger.
- the heat treatment and/or the step of cooling the nanofibrillar cellulose hydrogel are/is carried out in at least one heat exchanger .
- the heating apparatus is configured to heat the nanofibrillar cellulose up to a temperature of at least 130 °C in at most 0.5 seconds. In one embodiment, the heating apparatus is configured to heat the nanofibrillar cellulose up to a temperature of at least 133 °C in at most 0.5 seconds. In one embodiment, the heating apparatus is configured to heat the nanofibrillar cellulose up to a temperature of at least 135 °C in at most 0.5 seconds.
- the system comprises a cooling apparatus for cooling the nanofibrillar cellulose hydrogel to a temperature of below 30 °C in at most 120 seconds.
- the cooling apparatus is a heat exchanger.
- the system comprises a cooling apparatus, which is configured to cool the nanofibrillar cellulose hydrogel to a temperature of below 30 °C in at most 120 seconds.
- heating apparatus and the cooling apparatus is the same apparatus. In one embodiment the heating apparatus and the cooling apparatus are different apparatuses.
- the system comprises a packaging unit for packaging the treated nanofibrillar cellulose hydrogel.
- the packaging unit is configured to package the treated nanofibrillar cellulose hydrogel.
- the packaging unit packages the treated nanofibrillar cellulose hydrogel when in use.
- the nanofibrillar cellulose is native nanofibrillar cellulose or anionic nanofibrillar cellulose.
- Anionic nanofibrillar cellulose can be formed by pretreatment replacing at least part of the hydroxyl groups of cellulose with carboxyl groups. In one embodiment, of 10 - 15 % of the hydroxyl groups of cellulose are replaced with carboxyl groups.
- the anionic nanofibrillar cellulose is formed by oxidation of cellulose pulp fiber .
- native nanofibrillar cellulose has wider fibril diameter while the chemically modified, anionic nanofibrillar cellulose is much thinner and has a continuous network.
- the number average fibril diameter of the cellulose nanofibril is suitably from 1 - 200 nm, preferably the number average fibril diameter of native grades is 1 - 100 nm, and in chemically modified, anionic grades 1 - 20 nm. Size distribution is also narrower for the modified grades.
- the method comprises providing a nanofibrillar cellulose hydrogel having a viscosity of 2000 - 40000 mPa * s as measured at a 0.8% (w/w) concentration of the nanofibrillar cellulose in water with a Brookfield viscometer at a temperature of 20 °C, with a vane spindle and a measuring speed of 10 rpm.
- the method comprises providing anionic nanofibrillar cellulose hydrogel having a viscosity of 12000 - 30000 mPa * s as measured at a 0.8% (w/w) concentration of the nanofibrillar cellulose in water with a Brookfield viscometer at a temperature of 20 °C, with a vane spindle and a measuring speed of 10 rpm. .
- the weighting process is conducted following standard ISO 4119/1995 "Determination of stock concentration", with the difference that the time is 16 h.
- the so-called Brookfield viscosity measurement can be determined in the following manner: A vane spindle (number 73) is selected and the Brookfield- viscosity measuring apparatus (Brookfield RVDV-III) is started. A sample of the nanofibrillar cellulose is diluted to a concentration of 0.8 % by weight in water and mixed for 10 minutes using a propel mixer 700-800 rpm. No ultrasound mixing is used for modified grades, such as anionic nanofibrillar cellulose. The diluted sample mass is added to a 250 ml beaker and the temperature is adjusted to 20 °C ⁇ 1 °C, heated if necessary and mixed. The spindle is inserted in the beaker and measuring is started.
- Brookfield RVDV-III Brookfield- viscosity measuring apparatus
- the program registers 300 points starting with 0.5 rpm speed, then 300 points with 5 rpm and 10 rpm, and 100 points with 50 rpm and 100 rpm speeds. Relative viscosity is measured from each sample mass twice. Mean value and standard deviation are calculated for each sample, from results obtained from parallel measurements during last 5 seconds.
- method comprises providing a nanofibrillar cellulose hydrogel with a turbidity value of at most 200 NTU, or at most 90 NTU, or at most 40 NTU, as measured at a 0.1% (w/w) concentration of the nanofibrillar cellulose in water.
- the method comprises providing a nanofibrillar cellulose hydrogel with a turbidity value of 1 to 200 NTU, or 1 to 90 NTU, or 10 to 40 NTU, as measured at a 0.1% (w/w) concentration of the nanofibrillar cellulose in water.
- method comprises providing a nanofibrillar cellulose hydrogel with a turbidity value of 50 to 500 NTU, or 100 to 150 NTU as measured at a 0.1% (w/w) concentration of the nanofibrillar cellulose in water.
- HACH P2100 Turbidometer with a 50 ml measuring vessel is used for turbidity measurements.
- the calibration of the apparatus is checked and controlled with standard calibration bottles/samples.
- the dry matter of the nanofibrillar cellulose sample is determined and 0.5 g of the sample, calculated as dry matter, is loaded in the measuring vessel, which is filled with tap water to 500 g and vigorously mixed by shaking for about 30 s. Without delay the aqueous mixture is divided into 5 measuring vessels, which are inserted in the turbidometer . Three measurements on each vessel are carried out. Mean value and standard deviation are calculated for each sample.
- the viscosity of the nanofibrillar cellulose hydrogel, after the heat treatment differs at most 50 %, or at most 30 %, or at most 10 %, or at most 5 %, from the viscosity of the nanofibrillar cellulose hydrogel before the heat treatment, when the dry matter content of the nanofibrillar cellulose hydrogel subjected to the heat treatment is at least 0.6 weight-% and when the viscosity after the heat treatment is measured in the same dry matter content of at least 0.6 weight. I.e. the viscosity is measured in the same dry matter content before and after the heat treatment.
- the inventor of the present invention surprisingly found out that the heat treatment may not affect the viscosity of the hydrogel in an adverse manner in view of its further use in e.g. pharmaceutical or cosmetic products, or in cell culture.
- providing the nanofibrillar cellulose hydrogel comprises fibrillation of cellulose- based raw material.
- the nanofibrillar cellulose hydrogel is provided by fibrillation of cellulose pulp or refined pulp.
- Cellulose pulp can be used as cellulose-based raw material.
- Cellulose pulp can be formed by isolating cellulose fibers from raw material that contains cellulose by chemical, mechanical, thermo-mechanical, or chemithermo mechanical pulping processes, e.g. kraft pulping, sulfate pulping, soda pulping, organosolv pulping, and by conventional bleaching processes.
- fibrillation of cellulose-based raw material is carried out with a refiner, grinder, homogenizer, colloider, friction grinder, ultrasound sonicator, fluidizer such as microfluidizer, macrofluidizer or fluidizer-type homogenizer.
- a refiner grinder, homogenizer, colloider, friction grinder, ultrasound sonicator, fluidizer such as microfluidizer, macrofluidizer or fluidizer-type homogenizer.
- the step of pre-refining cellulose-based raw material is preceded the step of fibrillating the cellulose- based raw material.
- the dimensions of the fibrils or fibril bundles of the nanofibrillar cellulose are dependent on the raw material and the fibrillation method.
- fibrillation may be used interchangeably with expression disintegration, and generally refers to disintegrating cellulose-based raw material mechanically by work applied to the fibers, where cellulose fibrils are liberated from the fibers or fiber fragments.
- the work may be based on various effects, like grinding, crushing or shearing, or a combination of these, or another corresponding action that delaminates the cell walls of the fibers and liberates fibrils.
- the energy taken by the refining work is normally expressed in terms of energy per processed raw material quantity, in units of e.g. kWh/kg, MWh/ton, or units proportional to these.
- the disintegration is performed at conditions wherein water is sufficiently present to prevent the formation of bonds between the fibers .
- Nanofibrillar celluloses may contain hemicelluloses and lignin in varying amounts, depending on the plant source and pulping conditions.
- the cellulose- based raw material does not contain substantial amounts of lignin.
- the nanofibrillar cellulose is essentially free of lignin.
- providing the nanofibrillar cellulose hydrogel and subjecting the nanofibrillar cellulose hydrogel to heat treatment are carried out while maintaining aseptic conditions.
- the fibrillation unit and the heating apparatus are configured to maintain aseptic conditions.
- Maintaining aseptic conditions may refer to keeping the method for treating nanofibrillar cellulose hydrogel in a closed environment so that the product is transported in pipelines from one production step to the next. Ventilation air and dilution water used should be sterile. E.g. aseptic processing rooms in which air supply, materials, and/or equipment are regulated to control microbial and particle contamination can be used.
- the "aseptic conditions” refers to the conditions of ISO 14644-1 cleanroom standard ISO 9, or ISO 8, or ISO 5, or ISO 4, or ISO 3, or ISO 2, or ISO 1.
- the conditions of ISO 8 or ISO 9 are maintained before the step of subjecting the nanofibrillar cellulose hydrogel to the heat treatment.
- the heat treatment maintaining aseptic conditions are even more important than between the steps of providing the nanofibrillar cellulose hydrogel and of subjecting the nanofibrillar cellulose hydrogel to the heat treatment.
- the conditions of at least ISO 5 are maintained.
- the method for treating a nanofibrillar cellulose hydrogel is carried out in a continuous mode.
- the present invention relates further to a nanofibrillar cellulose hydrogel obtainable by the method according to the present invention.
- the present invention further relates to a nanofibrillar cellulose hydrogel, wherein the nanofibrillar cellulose hydrogel contains no colony- forming units of viable micro-organism per gram of nanofibrillar cellulose hydrogel, as measured by culturing on a growth medium, and has a viscosity of 2000 - 40000 mPa-s as measured at a 0.8% (w/w) concentration of the nanofibrillar cellulose in water with a Brookfield viscometer at a temperature of 20 °C, with a vane spindle and a measuring speed of 10 rpm.
- This kind of nanofibrillar cellulose hydrogel can be produced by the method described in this specification.
- the presence of viable micro-organisms in the nanofibrillar cellulose hydrogel can be determined by culturing on a growth medium. Several protocols for determining the number of colony forming units are available .
- the number of colony-forming units per gram of nanofibrillar cellulose hydrogel is determined by preparing a dilution series of the hydrogel and by plating the dilution series on separate Petrifilm plates (3M) for aerobic bacteria (aerobic plate count) and for yeasts and moulds.
- the plates for aerobic bacteria are allowed to grow at 37°C for 2 days and the plates for yeasts and moulds at 30°C for 3 - 5 days, after which the colonies are counted.
- the number of colony-forming units of aerobic heterotrophs are determined by culturing the sample on plate count agar at a temperature of 37°C for three (3) days.
- the presence of yeast and/or fungus can be determined by culturing on potato dextrose agar at a temperature of 25°C for five (5) days. Before the measurement, the samples are diluted by ten-fold.
- the presence of anaerobic micro-organisms can be determined by culturing on brewer anaerobic agar for anaerobic bacterial count at a temperature of 30 °C for three (3) days in anaerobic conditions. Before the measurement, the samples are diluted ten-fold.
- the number of colony-forming units is determined by following the standard ISO 8784- 1 (Pulp, Paper and board - Microbiological examination. Part 1: Total count of bacteria, yeast and mould based on disintegration) . The results are given as the number of colony-forming units per gram of the sample.
- the number of colony-forming units of viable micro-organism per gram of nanofibrillar cellulose hydrogel may be measured by incubating at 37 °C for 14 days following the USP XXIV Chapter 71 sterility test.
- treated nanofibrillar cellulose hydrogel contains at most 10 _1 , or at most 10 ⁇ 3 , or at most 10 ⁇ 6 , colony-forming units of a viable micro-organism per gram of nanofibrillar cellulose hydrogel .
- the present invention further relates to a nanofibrillar cellulose hydrogel for use in therapy, wherein the nanofibrillar cellulose hydrogel contains at most 10 _1 colony-forming units of viable micro ⁇ organism per gram of nanofibrillar cellulose hydrogel, and has a viscosity of 2000 - 40000 mPa * s as measured at a 0.8% (w/w) concentration of the nanofibrillar cellulose in water with a Brookfield viscometer at a temperature of 20 °C, with a vane spindle and a measuring speed of 10 rpm.
- the nanofibrillar cellulose hydrogel for use in therapy contains at most 10 ⁇ 3 , or at most 10 ⁇ 6 , colony-forming units of viable micro-organism per gram of the nanofibrillar cellulose hydrogel.
- the present invention further relates to a nanofibrillar cellulose hydrogel obtainable by the method according to the present invention for use in therapy .
- the present invention further relates to the use of nanofibrillar cellulose hydrogel in a cosmetic product, wherein the nanofibrillar cellulose hydrogel contains no colony-forming units of viable micro- organism per gram of nanofibrillar cellulose hydrogel, as measured by culturing on a growth medium, and has a viscosity of 2000 - 40000 mPa * s as measured at a 0.8% (w/w) concentration of the nanofibrillar cellulose in water with a Brookfield viscometer at a temperature of 20 °C, with a vane spindle and a measuring speed of 10 rpm.
- the present invention further relates to the use of nanofibrillar cellulose hydrogel obtainable by the method according to the present invention in a cosmetic product.
- the present invention further relates to the use of nanofibrillar cellulose hydrogel in cell culture, wherein the nanofibrillar cellulose hydrogel contains at most 10 ⁇ 2 colony-forming units of viable micro-organism per gram of nanofibrillar cellulose hydrogel, and has a viscosity of 2000 - 40000 mPa * s as measured at a 0.8% (w/w) concentration of the nanofibrillar cellulose in water with a Brookfield viscometer at a temperature of 20 °C, with a vane spindle and a measuring speed of 10 rpm.
- the present invention further relates to the use of nanofibrillar cellulose hydrogel obtainable by the method according to the present invention in cell culture .
- the nanofibrillar cellulose hydrogel which is used in cell culture contains at most 10 ⁇ 3 , or at most 10 ⁇ 6 , colony-forming units of viable micro-organism per gram of the nanofibrillar cellulose hydrogel.
- a method, a hydrogel, a system, or a use, to which the invention is related, may comprise at least one of the embodiments of the invention described hereinbefore.
- nanofibrillar cellulose hydrogel can be treated in order to reduce the number of viable micro-organisms therein without compromising, in an adverse extent, other properties such as viscosity thereof.
- An advantage of the method according to the present invention is that in addition to reducing the number of viable micro-organisms in the nanofibrillar cellulose hydrogel, also any possibly present proteins are denaturated and thus inactivated.
- An advantage of the method according to the present invention is that the heat treatment can easily be combined with the step of providing the nanofibrillar cellulose hydrogel as well as e.g. the packaging step thereof following the heat treatment.
- An advantage of the method according to the present invention is that a nanofibrillar cellulose hydrogel can be provided for use in pharmaceutical or cosmetic applications.
- An advantage of the method according to the present invention is that biocides are not needed to reduce the number of viable micro ⁇ organisms in the nanofibrillar cellulose hydrogel. In some cases, depending on the end-use of the treated nanofibrillar cellulose hydrogel, a minor amount of biocide can be used in order to reach a required purity level .
- Figure 1 illustrates a system according to one embodiment of the present invention for treating a nanofibrillar cellulose hydrogel.
- the system comprises a fibrillation unit 1 for providing a nanofibrillar cellulose hydrogel.
- the fibrillation unit is configured to fibrillate a cellulose-based raw material.
- the cellulose-based raw material can be e.g. cellulose pulp, which is disintegrated in e.g. a fluidizer or homogenizer .
- the produced nanofibrillar cellulose hydrogel is then provided into heating apparatus 2, wherein it is subjected to a heat treatment.
- the heating apparatus is configured to keep the nanofibrillar cellulose hydrogel at a temperature of at least 130 °C for at least 0.5 seconds, for reducing the number of viable micro-organisms in the nanofibrillar cellulose hydrogel .
- the nanofibrillar cellulose hydrogel is provided into a cooling apparatus 3, which, in this embodiment, is a separate apparatus from the heating apparatus.
- the heating apparatus could be configured to cool the nanofibrillar cellulose hydrogel to a temperature of below 30 °C in at most 120 seconds after the heat treatment.
- TEMPO-oxidation is a well- known process in the art.
- TEMPO-oxidation is catalytic oxidation of cellulose carried out by using a heterocyclic nitroxyl radical, i.e. 2,2,6,6- tetramethylpiperidinyl-l-oxy free radical.
- the pulp was fibrillated to produce nanofibrillar cellulose hydrogels.
- the hydrogel was manufactured to a dry matter content of 1.14 %.
- the viscosity of the nanofibrillar cellulose hydrogel was 18000 mPa * S when diluted to 0.77 %.
- nanofibrillar cellulose hydrogels were measured for microbial growth by culturing on growth medium in a manner as above described.
- the different samples were subjected to heat treatment at 131 °C for 5 seconds or 140 °C for 10 seconds.
- the used apparatus was MicroThermics , Lab-25 HV Hybrid, where the heat treatment is based on the use of indirect steam. Table 1 below indicates the different measured parameters and the treatment procedures.
- the hydrogel contained a lot of viable micro-organisms, especially aerobic bacteria and aerobic yeast and mould.
- the culturing plates were full of microbial growth.
- the results from microbial growth tests after the heat treatment indicated that all aerobic bacteria as well as aerobic yeast and moulds were killed as a result of the heat treatment.
- the treatment of nanofibrillar cellulose hydrogel at a high temperature for a rather short period of time provides the effect of reducing the number of viable micro-organisms but does not affect the viscosity of the nanofibrillar cellulose hydrogel to an adverse extent when the dry matter content of the nanofibrillar cellulose hydrogel is at least 0.6 % .
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20146139A FI125884B2 (en) | 2014-12-22 | 2014-12-22 | Treatment of a high temperature nanofibrillar cellulose hydrogel |
PCT/FI2015/050918 WO2016102766A1 (fr) | 2014-12-22 | 2015-12-21 | Traitement d'hydrogel de cellulose nanofibrillaire à température élevée |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3237108A1 true EP3237108A1 (fr) | 2017-11-01 |
EP3237108B1 EP3237108B1 (fr) | 2020-07-01 |
Family
ID=55229738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15828499.2A Active EP3237108B1 (fr) | 2014-12-22 | 2015-12-21 | Traitement d'hydrogel de cellulose nanofibrillaire à température élevée |
Country Status (4)
Country | Link |
---|---|
US (1) | US10625232B2 (fr) |
EP (1) | EP3237108B1 (fr) |
FI (1) | FI125884B2 (fr) |
WO (1) | WO2016102766A1 (fr) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1027835B1 (fr) | 1997-10-23 | 2008-09-17 | Morinaga Milk Industry Co., Ltd. | Procede et dispositif permettant de steriliser thermiquement en continu un liquide |
JP4451352B2 (ja) | 2005-05-31 | 2010-04-14 | 理研ビタミン株式会社 | ホイップクリーム用水中油型乳化組成物 |
FI123988B (fi) | 2010-10-27 | 2014-01-31 | Upm Kymmene Corp | Soluviljelymateriaali |
FI123694B (en) * | 2011-12-22 | 2013-09-30 | Upm Kymmene Corp | Matrix and composition for microbial culture of gram-positive bacteria |
FI126118B (en) | 2012-02-10 | 2016-06-30 | Upm Kymmene Corp | Process for pretreatment of cellulose pulp |
FI126847B (en) | 2012-12-13 | 2017-06-15 | Upm Kymmene Corp | Process for catalytic oxidation of cellulose and process for producing a cellulose product |
FI126109B (en) * | 2013-02-22 | 2016-06-30 | Upm Kymmene Corp | Nanofibril polysaccharide for use in the control and prevention of constriction and scarring |
-
2014
- 2014-12-22 FI FI20146139A patent/FI125884B2/en active IP Right Grant
-
2015
- 2015-12-21 US US15/538,067 patent/US10625232B2/en active Active
- 2015-12-21 WO PCT/FI2015/050918 patent/WO2016102766A1/fr active Application Filing
- 2015-12-21 EP EP15828499.2A patent/EP3237108B1/fr active Active
Also Published As
Publication number | Publication date |
---|---|
FI20146139A (fi) | 2016-03-31 |
FI125884B (en) | 2016-03-31 |
WO2016102766A1 (fr) | 2016-06-30 |
US20170348662A1 (en) | 2017-12-07 |
US10625232B2 (en) | 2020-04-21 |
FI125884B2 (en) | 2019-03-29 |
EP3237108B1 (fr) | 2020-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO341867B1 (no) | Fremgangsmåte for fremstilling av mikrofibrillert cellulose | |
US10822743B2 (en) | Process for producing a nanofibrillar cellulose hydrogel | |
US11555079B2 (en) | Process for producing an oxidized nanofibrillar cellulose hydrogel | |
Tozluoglu et al. | Examining the efficiency of mechanic/enzymatic pretreatments in micro/nanofibrillated cellulose production | |
US10322196B2 (en) | Heat treatment of a nanofibrillar cellulose hydrogel | |
US11918966B2 (en) | Treating catalytically oxidized nanofibrillar cellulose hydrogel | |
EP3350368B1 (fr) | Procede pour la fabrication de la cellulose nanofibrillaire | |
US10625232B2 (en) | Treating nanofibrillar cellulose hydrogel at elevated temperature | |
DK3237109T3 (en) | METHOD OF REDUCING THE VISCOSITY OF A NANOFIBRILLARY CELLULOSE HYDROGEN | |
CN112739759B (zh) | 颗粒状纤维素产品 | |
JP7156761B2 (ja) | バクテリオファージの保存のための組成物またはマトリックス |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170620 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20190211 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200225 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1285630 Country of ref document: AT Kind code of ref document: T Effective date: 20200715 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602015055187 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NO Ref legal event code: T2 Effective date: 20200701 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ARNOLD AND SIEDSMA AG, CH |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201001 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200701 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1285630 Country of ref document: AT Kind code of ref document: T Effective date: 20200701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201002 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201102 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201101 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602015055187 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
26N | No opposition filed |
Effective date: 20210406 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20201231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201221 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201231 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230529 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231227 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20231227 Year of fee payment: 9 Ref country code: NO Payment date: 20231227 Year of fee payment: 9 Ref country code: FR Payment date: 20231227 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20231229 Year of fee payment: 9 Ref country code: CH Payment date: 20240101 Year of fee payment: 9 |